Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 993Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Orion Corporation

02 3AA PHARMA INC

03 3APOTEX INC

04 6PFIZER CANADA ULC

05 3PHARMASCIENCE INC

06 3PRO DOC LIMITEE

07 3Pharmascience Inc.

08 1SANDOZ CANADA INCORPORATED

09 3TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : ATIVAN

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 100

Approval Date :

Application Number : 2041456

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : ATIVAN

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : 100

Approval Date :

Application Number : 2041472

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : ATIVAN

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : 100/1000

Approval Date :

Application Number : 2041448

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : ATIVAN

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 100/1000

Approval Date :

Application Number : 2041421

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : ATIVAN

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 100/500

Approval Date :

Application Number : 2041413

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Lorazepam

Brand Name : PMS-LORAZEPAM TAB 1MG

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Lorazepam

Brand Name : PMS-LORAZEPAM TAB 2MG

Dosage Form : TABLET

Dosage Strength : 2MG

Packaging : 100/1000

Approval Date :

Application Number :

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Lorazepam

Brand Name : PMS-LORAZEPAM TAB 0.5MG

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

LORAZEPAM

Brand Name : PMS-LORAZEPAM

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 100

Approval Date :

Application Number : 728195

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank